We are live on ! Find out more
BFRIW icon

Biofrontera

6 hedge funds and large institutions have $7.27K invested in Biofrontera in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

12.55% less ownership

Funds ownership: 16.56%4.01% (-13%)

14% less funds holding

Funds holding: 76 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

52% less capital invested

Capital invested by funds: $15K → $7.27K (-$7.73K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$6.32K -$204 -4,000 -2%
Citadel Advisors
2
Citadel Advisors
Florida
$465 +$49 +950 +9%
CS
3
Clear Street
New York
$407
Osaic Holdings
4
Osaic Holdings
Arizona
$44
US Bancorp
5
US Bancorp
Minnesota
$35
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-$1.15K -16,962 Closed
UBS Group
7
UBS Group
Switzerland
-$133 -2,594 -100%

BFRIW Hedge Fund Activity: Q2 2024 in Review

6 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q2 2024, worth a combined $7.27K — down 52% from $15K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, adding an estimated $49. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.15K sold.

  • 6 institutional investors held Biofrontera (BFRIW) as of Q2 2024, down from 7 in Q1 2024.
  • Funds reported $7.27K of Biofrontera stock for Q2 2024, down 52% quarter-over-quarter.
  • 0 funds opened new Biofrontera positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest Biofrontera buyer in Q2 2024 was Citadel Advisors, an estimated $49 added.
  • The largest Biofrontera seller in Q2 2024 was Susquehanna International Group, an estimated $1.15K sold.

Based on aggregated 13F filings for Q2 2024.